Atlas Trials

TD-6450 MAD Study in HCV Infected Subjects

Clinical trial NCT02116543 · COMPLETED

Trial details

NCT number
NCT02116543
Sponsor
Theravance Biopharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis CHCV
Start date
2014-05-01
Primary completion
2014-10-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.